3B
3E Bioventures
Venture CapitalActive3E Bioventures is a venture capital firm specializing in growth capital.
22
Investments
1
Exits
—
AUM
4.5%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for 3E Bioventures.
Investment Thesis & Strategy
3E Bioventures invests growth capital in various stages across a range of industries. They focus on companies with high growth potential.
Investment Activity
Deals per year over the last 7 years
1
20150
20162
20170
20180
20190
20206
2021Portfolio Companies
Selected investments from their portfolio of 22 companies
Z
Zhejiang Weiming
Biotech · Growth, 2021
E
Elpiscience
Biotech · Series B, 2021
R
RemeGen
Biotech · Growth, 2021
T
TransThera Biosciences
Biotech · Series B, 2021
E
EpimAb Biotherapeutics
Biotech · Series B, 2021
A
Adlai Nortye
Biotech · Growth, 2021
I
I-Mab
Biotech · Growth, 2017
H
Harbour BioMed
Biotech · Growth, 2017
I
Innovent Biologics
Biotech · Growth, 2015
Frequently Asked Questions
3E Bioventures focuses on Series A, Series B, Series C+ stage investments.